The Central Epidemic Command Center (CECC) said on Sunday it is considering purchasing an experimental pill that, according to its makers, significantly reduces the risk of hospitalization or death from COVID-19.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
TPP chair leads delegation to U.S. for talks on arms procurement, tariffs
01/11/2026 09:16 PM - Society
Death penalty advocates march in Taipei ahead of child abuse verdict
01/11/2026 09:11 PM - Society
Lai announces approval of NT$2.94 billion 'smart health' subsidies
01/11/2026 08:22 PM - Business
Yamaha Motor Taiwan becomes wholly owned by Japanese parent
01/11/2026 07:21 PM - Society
Taiwan to publish new dietary guidelines in Q2 2026: Minister
01/11/2026 06:48 PM